Olivia M Dong (Olivia Dong)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Percutaneous Coronary Intervention

St Segment Elevation Myocardial Infarction

Health Insurance

Top Venues

PharmacoEconomics

Pharmacogenomics

Pharmacy (Basel, Switzerland)

European heart journal. Quality of care & clinical outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
Olivia M Dong, Kevin A Friede, Catherine Chanfreau-Coffinier, Deepak Voora
Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes. European heart journal. Quality of care & clinical outcomes (2022)
Olivia M Dong, Megan C Roberts, R Ryanne Wu, Corrine I Voils, Nina Sperber, Kara L Gavin, Jill Bates, Catherine Chanfreau-Coffinier, Michael Naglich, Michael J Kelley, Jason L Vassy, Peruvemba Sriram, C William Heise, Salvador Rivas, Maria Ribeiro, Jennifer G Chapman, Deepak Voora
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. Pharmacogenomics 22 (17) (2021)
Olivia M Dong, Jill Bates, Catherine Chanfreau-Coffinier, Michael Naglich, Michael J Kelley, Laurence J Meyer, Michael Icardi, Jason L Vassy, Peruvemba Sriram, Craig William Heise, Salvador Rivas, Maria Ribeiro, Russell Jacobitz, Susan Rozelle, Jennifer G Chapman, Deepak Voora
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program. Pharmacogenomics 22 (3) (2021)
Amber Frick, Cristina Benton, Oscar Suzuki, Olivia M Dong, Rachel Howard, Hijrah El-Sabae, Tim Wiltshire
Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping. Pharmacy (Basel, Switzerland) 6 (4) (2018)